BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6538936)

  • 1. Characterization of forskolin binding sites in rat brain membranes using [14,15-3H]14,15-dihydroforskolin as a ligand.
    Schmidt K; Munshi R; Baer HP
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):153-8. PubMed ID: 6538936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of [14,15-3H]14,15-dihydroforskolin to rat liver membranes: comparison with the stimulatory effect of forskolin on adenylate cyclase.
    Schmidt K; Baer HP; Shariff A; Ayer WA; Browne L
    Can J Physiol Pharmacol; 1987 May; 65(5):803-9. PubMed ID: 3621043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forskolin binding sites in rat liver and brain membranes.
    Schmidt K; Baer HP
    Eur J Pharmacol; 1983 Oct; 94(3-4):337-40. PubMed ID: 6686143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a single forskolin-binding site in rat adipocyte membrane. Studies of [14,15-3H]dihydroforskolin binding and adenylate cyclase activation.
    Ho RJ; Shi QH
    J Biol Chem; 1984 Jun; 259(12):7630-6. PubMed ID: 6539776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [3H]forskolin to rat brain membranes.
    Seamon KB; Vaillancourt R; Edwards M; Daly JW
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5081-5. PubMed ID: 6433343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of [3H]forskolin to solubilized preparations of adenylate cyclase.
    Nelson CA; Seamon KB
    Life Sci; 1988; 42(14):1375-83. PubMed ID: 3352459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forskolin-mediated activation of cardiac, liver and lung adenylate cyclase in the rat. Relation to [3H]forskolin binding sites.
    Jackman GP; Bobik A
    Biochem Pharmacol; 1986 Jul; 35(13):2247-51. PubMed ID: 3729979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deacetylation of forskolin catalyzed by bovine brain membranes.
    Selfe S; Storm DR
    Biochem Biophys Res Commun; 1985 Nov; 133(1):52-9. PubMed ID: 4074378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase.
    Laurenza A; Robbins JD; Seamon KB
    Mol Pharmacol; 1992 Feb; 41(2):360-8. PubMed ID: 1538712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of the cardiac effects of forskolin by specific binding sites.
    Schmidt K; Kukovetz WR
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):353-60. PubMed ID: 2471879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of skeletal muscle beta-adrenergic receptors coupled to adenylate cyclase.
    Reddy NB; Engel WK
    Biochim Biophys Acta; 1979 Jul; 585(3):343-59. PubMed ID: 226166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for forskolin binding sites in rat myocardium.
    Schmidt K; Kukovetz WR
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):425-38. PubMed ID: 4067032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
    Joost HG; Habberfield AD; Simpson IA; Laurenza A; Seamon KB
    Mol Pharmacol; 1988 Apr; 33(4):449-53. PubMed ID: 3357486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autoradiographic localization of adenylate cyclase in rat kidney using [3H]forskolin.
    McMartin LR; Summers RJ
    Biochem Pharmacol; 1990 Mar; 39(6):1019-28. PubMed ID: 2322290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forms of adenylate cyclase, activation and/or potentiation by forskolin.
    Shi QH; Ruiz JA; Ho RJ
    Arch Biochem Biophys; 1986 Nov; 251(1):156-65. PubMed ID: 3789730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]-forskolin binding sites in rat submandibular salivary glands.
    Ren YF; Ahmad SN; Alam BS; Alam SQ
    Arch Oral Biol; 1988; 33(11):779-82. PubMed ID: 3257083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship among calmodulin-, forskolin-, and guanine nucleotide-dependent adenylate cyclase activities in cerebellar membranes: studies by limited proteolysis.
    Malnoë A; Cox JA
    J Neurochem; 1985 Oct; 45(4):1163-71. PubMed ID: 4040955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.
    Hüttemann E; Ukena D; Lenschow V; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):226-33. PubMed ID: 6328333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.